Last reviewed · How we verify
Eurartesim dispersible oral tablet
Eurartesim dispersible oral tablet is a antimalarial Small molecule drug developed by sigma-tau i.f.r. S.p.A.. It is currently in Phase 2 development for Uncomplicated Plasmodium falciparum malaria. Also known as: Piperaquine tetraphosphate plus dihydroartemisinin.
Eurartesim is a fixed-dose combination of dihydroartemisinin and piperaquine, targeting the hemozoin formation in Plasmodium parasites to treat malaria.
Eurartesim is a fixed-dose combination of dihydroartemisinin and piperaquine, targeting the hemozoin formation in Plasmodium parasites to treat malaria. Used for Uncomplicated Plasmodium falciparum malaria.
At a glance
| Generic name | Eurartesim dispersible oral tablet |
|---|---|
| Also known as | Piperaquine tetraphosphate plus dihydroartemisinin |
| Sponsor | sigma-tau i.f.r. S.p.A. |
| Drug class | antimalarial |
| Target | hemozoin formation in Plasmodium parasites |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 2 |
Mechanism of action
Dihydroartemisinin rapidly kills the asexual blood stages of Plasmodium falciparum by disrupting hemozoin formation and inducing oxidative stress, while piperaquine provides longer-lasting prophylactic activity against the parasite.
Approved indications
- Uncomplicated Plasmodium falciparum malaria
Common side effects
- headache
- dizziness
- nausea
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Eurartesim dispersible oral tablet CI brief — competitive landscape report
- Eurartesim dispersible oral tablet updates RSS · CI watch RSS
- sigma-tau i.f.r. S.p.A. portfolio CI
Frequently asked questions about Eurartesim dispersible oral tablet
What is Eurartesim dispersible oral tablet?
How does Eurartesim dispersible oral tablet work?
What is Eurartesim dispersible oral tablet used for?
Who makes Eurartesim dispersible oral tablet?
Is Eurartesim dispersible oral tablet also known as anything else?
What drug class is Eurartesim dispersible oral tablet in?
What development phase is Eurartesim dispersible oral tablet in?
What are the side effects of Eurartesim dispersible oral tablet?
What does Eurartesim dispersible oral tablet target?
Related
- Drug class: All antimalarial drugs
- Target: All drugs targeting hemozoin formation in Plasmodium parasites
- Manufacturer: sigma-tau i.f.r. S.p.A. — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for Uncomplicated Plasmodium falciparum malaria
- Also known as: Piperaquine tetraphosphate plus dihydroartemisinin
- Compare: Eurartesim dispersible oral tablet vs similar drugs
- Pricing: Eurartesim dispersible oral tablet cost, discount & access